Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations.

导出 LinkOut

翻译打印收藏纠错

作者： Kevin J,Frost ^[1] ; Ryan A,Hamilton ^[2] ; Stephen,Hughes ^[3] ; Conor,Jamieson ^[4] ; Paul,Rafferty ^[5] ; Oliver,Troise ^[6] ; Abi,Jenkins ^[4]

作者单位： Airedale NHS Foundation Trust, Keighley, UK kevin.frost@nhs.net. ^[1] Pharmacy, De Montfort University, Leicester, UK. ^[2] Pharmacy, Kettering General Hospital NHS Foundation Trust, Kettering, UK. ^[3] Pharmacy, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK. ^[4] NHS England and NHS Improvement Midlands, Birmingham, UK. ^[5] Pharmacy, Southern Health and Social Care Trust, Portadown, UK. ^[6] University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. ^[7]

关键词 clinical medicine evidence-based medicine microbiology pharmacokinetics pharmacology safety therapeutic drug monitoring

主题词成年人(Adult);老年人(Aged);人类(Humans);丁胺卡那霉素(Amikacin);临床方案(Clinical Protocols)

DOI 10.1136/ejhpharm-2022-003421

PMID 36344247

发布时间 2024-07-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

European journal of hospital pharmacy

2023年30卷4期

189-195页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations.

European journal of hospital pharmacy

相似文献

European journal of hospital pharmacy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations.

European journal of hospital pharmacy

相似文献

European journal of hospital pharmacy

相关期刊

检索历史清除